Scaling Genome Editing From Discovery to Manufacturing
Fill out the form below, and we shall send your colleague an invitation to the "Scaling Genome Editing From Discovery to Manufacturing" event.
Scaling genome editing workflows remains a significant challenge for cell therapy developers. Achieving efficient editing in primary cells, while maintaining reproducibility across research and manufacturing workflows, is essential for advancing next-generation therapies.
In this webinar, our expert speaker will discuss how non-viral electroporation-based genome editing supports applications ranging from CRISPR screening to complex cell engineering.
Through practical examples and recent advances in scalable electroporation, attendees will gain insights into developing more efficient, reproducible workflows that can support the transition from early research toward clinical manufacturing.
Attend this webinar to:
- Understand practical approaches for efficient, non-viral delivery of DNA, RNA, and CRISPR cargo into primary cells
- Explore advanced gene editing applications, including multiplex knockouts and large DNA knock-ins
- Discover CRISPR screening approaches for drug discovery and target identification
- Learn about the applications in next-generation cell and gene therapies, including engineered T cells
